The Innovation and Technology Bureau acts as a bridge in creating a vibrant ecosystem for the government, industry, academia and the research sector with excellent software and hardware support. To understand players within the healthcare technology industry, the director of ITB, Mr. Nicholas Yang Wei-Hsiung visited Sanwa BioTech and discussed with the SBT team about development plans and supports that could better aid in the development of the industry. In the visit, the ALiA platform along with our multiplex BioChip was also demonstrated.
Thanks to the ITB’s dedication in building Hong Kong into an innovation hub for technology, Sanwa BioTech had now developed into one of the industry recognized next generation platforms with vertical production capabilities & knowhow.
